Oracle faces investor angst ahead of earnings as OpenAI exposure, rising capex and debt reliance weigh on shares despite massive AI-driven backlog growth.

Snowflake Inc. is rated a Strong Buy due to strong revenue growth and high free cash flow margins. Learn more about SNOW ...

As you can see from the graphic, over the past five years, XLK has outperformed FTEC by 8.6%. Apparently, that is enough for ...

Wall Street’s rally of U.S. stocks in 2023 and 2024 continued in 2025, albeit at a slow pace. The rally was predominantly ...

Dividend stocks (which commonly are value stocks, but can be growth stocks) are great ways to drive long-term performance of ...

Hackers thought to be aligned with China and Russia are suspected to be behind a wave of account takeover attacks targeting Microsoft 365 users.

In fiscal 2025, which ended on June 30, Microsoft spent $18.42 billion on stock buybacks and $24.08 billion on dividends. In ...

For equity investors seeking a smooth ride in 2026, increasing exposure beyond artificial intelligence euphoria could be a ...

Wondering if Astellas Pharma is still worth buying after its big run, or if the easy money has already been made? In this article, we walk through what the market is pricing in and where the gaps ...

If you are wondering whether Argan's massive run makes it a buy, hold, or no-go at today's price, you are in the right place for a clear headed valuation breakdown. After a jaw dropping 127.2% year to ...

Healthcare AI moved beyond the pilot phase in 2025. From saving hundreds of lives to reducing costs by $20 million to more than $100 million annually, health systems started experiencing measurable ...